National Health Investors, Inc. (NYSE:NHI) Receives $85.57 Average PT from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have received a consensus rating of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $85.5714.

Several research analysts have weighed in on NHI shares. Wells Fargo & Company boosted their price target on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. KeyCorp upped their target price on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price on the stock. in a research report on Tuesday, January 20th. Truist Financial lifted their price target on National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a report on Monday, December 15th. Finally, National Bankshares set a $85.00 price objective on shares of National Health Investors in a report on Tuesday, January 20th.

National Health Investors Price Performance

NYSE:NHI opened at $82.17 on Monday. National Health Investors has a 12-month low of $65.22 and a 12-month high of $82.34. The firm has a market cap of $3.91 billion, a price-to-earnings ratio of 25.92, a price-to-earnings-growth ratio of 2.76 and a beta of 0.67. The company’s 50-day moving average is $78.30 and its two-hundred day moving average is $76.60. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. The business had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The company’s revenue was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.03 earnings per share. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. Research analysts expect that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st were paid a dividend of $0.92 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a yield of 4.5%. National Health Investors’s dividend payout ratio (DPR) is currently 116.09%.

Institutional Trading of National Health Investors

Institutional investors have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC raised its position in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares during the period. GAMMA Investing LLC increased its stake in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 136 shares during the last quarter. Key Capital Management INC purchased a new position in shares of National Health Investors in the 4th quarter worth about $47,000. Assetmark Inc. lifted its stake in shares of National Health Investors by 19.0% in the 2nd quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock valued at $65,000 after purchasing an additional 148 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new position in shares of National Health Investors in the 3rd quarter valued at about $65,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.